Kerri-Ann Millar
2019
In 2019, Kerri-Ann Millar earned a total compensation of $448.3K as Chief Financial Officer at Cue Biopharma.
Compensation breakdown
| Bonus | $82,775 |
|---|---|
| Option Awards | $146,454 |
| Salary | $215,000 |
| Other | $4,092 |
| Total | $448,321 |
Millar received $215K in salary, accounting for 48% of the total pay in 2019.
Millar also received $82.8K in bonus, $146.5K in option awards and $4.1K in other compensation.
Rankings
In 2019, Kerri-Ann Millar's compensation ranked 12,058th out of 13,971 executives tracked by ExecPay. In other words, Millar earned more than 13.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,058 out of 13,971 | 14th |
Division Manufacturing | 4,886 out of 5,701 | 14th |
Major group Chemicals And Allied Products | 1,927 out of 2,200 | 12th |
Industry group Drugs | 1,661 out of 1,886 | 12th |
Industry Pharmaceutical Preparations | 1,231 out of 1,398 | 12th |
Source: SEC filing on April 26, 2021.
Millar's colleagues
We found three more compensation records of executives who worked with Kerri-Ann Millar at Cue Biopharma in 2019.